Skip to main content

Lipocine Inc.

LPCN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001535955

No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Lipocine Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
36
−11 vs. Q1 2026
Shares held
2.98M
−298.4K (−9.1%) vs. Q1 2026
Total value
$7.63M
−$18.6M (−70.9%) vs. Q1 2026
New holders
4
14 more added
Sold out
15
3 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LPCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 36 institutions
Q1 2021: 42 institutionsQ2 2021: 33 institutionsQ3 2021: 38 institutionsQ4 2021: 39 institutionsQ1 2022: 44 institutionsQ2 2022: 46 institutionsQ3 2022: 46 institutionsQ4 2022: 49 institutionsQ1 2023: 45 institutionsQ2 2023: 24 institutionsQ3 2023: 21 institutionsQ4 2023: 19 institutionsQ1 2024: 18 institutionsQ2 2024: 19 institutionsQ3 2024: 18 institutionsQ4 2024: 17 institutionsQ1 2025: 19 institutionsQ2 2025: 18 institutionsQ3 2025: 22 institutionsQ4 2025: 26 institutionsQ1 2026: 47 institutionsQ2 2026: 36 institutions
Value heldQ2 2026: $7.63M
Q1 2021: $12.4MQ2 2021: $12.8MQ3 2021: $10.0MQ4 2021: $10.7MQ1 2022: $102.0MQ2 2022: $9.54MQ3 2022: $4.85MQ4 2022: $4.16MQ1 2023: $16.6MQ2 2023: $2.40MQ3 2023: $1.48MQ4 2023: $1.35MQ1 2024: $2.47MQ2 2024: $4.38MQ3 2024: $2.45MQ4 2024: $2.38MQ1 2025: $1.65MQ2 2025: $1.67MQ3 2025: $1.51MQ4 2025: $13.1MQ1 2026: $26.2MQ2 2026: $7.63M
Institutions holding LPCN and their total value by quarter
QuarterHoldersValue
Q2 202636$7.63M
Q1 202647$26.2M
Q4 202526$13.1M
Q3 202522$1.51M
Q2 202518$1.67M
Q1 202519$1.65M
Q4 202417$2.38M
Q3 202418$2.45M
Q2 202419$4.38M
Q1 202418$2.47M
Q4 202319$1.35M
Q3 202321$1.48M
Q2 202324$2.40M
Q1 202345$16.6M
Q4 202249$4.16M
Q3 202246$4.85M
Q2 202246$9.54M
Q1 202244$102.0M
Q4 202139$10.7M
Q3 202138$10.0M
Q2 202133$12.8M
Q1 202142$12.4M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Lipocine Inc.; share changes are against Q1 2026.

Institutions holding LPCN in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Squadron Capital Management LLC810,000$2.07M0.71%+360,000+80.0%Added
Ikarian Capital, LLC508,556$1.30M0.21%00.0%Unchanged
Eversept Partners, LP294,989$755.2K0.04%00.0%Unchanged
Vanguard Capital Management LLC230,823$590.9K0.00%+30,155+15.0%Added
Acadian Asset Management LLC170,417$435.0K0.00%+170,417New
Boothbay Fund Management, LLC140,487$359.6K0.01%00.0%Unchanged
Jane Street Group, LLC95,227$243.8K0.00%+75,200+375.5%Added
BlackRock, Inc.89,272$228.5K0.00%00.0%Unchanged
Two Sigma Investments, LP84,887$217.3K0.00%+51,137+151.5%Added
Citadel Advisors LLC81,221$207.9K0.00%+52,133+179.2%Added
Seven Fleet Capital Management LP78,842$201.8K0.03%−46,100−36.9%Reduced
Geode Capital Management, LLC74,477$190.8K0.00%+11,342+18.0%Added
Renaissance Technologies LLC69,209$177.2K0.00%+30,712+79.8%Added
Vanguard Fiduciary Trust Co54,539$139.6K0.00%+22,126+68.3%Added
Dimensional Fund Advisors LP36,775$94.1K0.00%+17,653+92.3%Added
HRT Financial LP29,238$74.0K0.00%+29,238New
Susquehanna International Group, LLP25,376$65.0K0.00%+468+1.9%Added
State Street Corp22,407$57.4K0.00%00.0%Unchanged
Gsa Capital Partners LLP18,666$48.0K0.00%+18,666New
Birchview Capital, LP16,712$42.8K0.02%−95,074−85.1%Reduced
Northern Trust Corp15,942$40.8K0.00%+2,900+22.2%Added
Price T Rowe Associates Inc12,266$32.0K0.00%+12,266New
Barclays PLC9,827$25.2K0.00%+415+4.4%Added
UBS Group AG3,596$9.21K0.00%+102+2.9%Added
Wells Fargo & Company2,706$6.93K0.00%00.0%Unchanged
Vanguard Global Advisers, LLC1,691$4.33K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)678$1.74K0.00%−255−27.3%Reduced
Morgan Stanley574$1.47K0.00%00.0%Unchanged
Caldwell Sutter Capital, Inc.471$1.21K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.238$6090.00%+95+66.4%Added
Group One Trading, L.P.132$3380.00%00.0%Unchanged
PlanVest Financial, Inc111$2840.00%00.0%Unchanged
SBI Securities Co., Ltd.67$1720.00%00.0%Unchanged
Tidemark, LLC59$1510.00%00.0%Unchanged
Bogart Wealth, LLC3$80.00%00.0%Unchanged
Farther Finance Advisors, LLC1$30.00%00.0%Unchanged
StemPoint Capital LP0$00.00%−320,840−100.0%Sold out
Rosalind Advisors, Inc.0$00.00%−221,616−100.0%Sold out
AIGH Capital Management LLC0$00.00%−200,000−100.0%Sold out
Mink Brook Asset Management LLC0$00.00%−66,812−100.0%Sold out
Exome Asset Management LLC0$00.00%−60,861−100.0%Sold out
Diadema Partners LP0$00.00%−50,000−100.0%Sold out
J. Goldman & Co LP0$00.00%−42,170−100.0%Sold out
ADAR1 Capital Management, LLC0$00.00%−23,180−100.0%Sold out
XTX Topco Ltd0$00.00%−17,923−100.0%Sold out
Persistent Asset Partners Ltd0$00.00%−13,442−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−12,630−100.0%Sold out
Ameriprise Financial Inc0$00.00%−11,448−100.0%Sold out
FMR LLC0$00.00%−626−100.0%Sold out
JPMorgan Chase & Co0$00.00%−392−100.0%Sold out
Royal Bank of Canada0$00.00%−50−100.0%Sold out